Roger V Ortines Selected Research

Rifampin (Rifampicin)

4/2017

Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger V Ortines Research Topics

Disease

11	Infections 10/2022 - 01/2017
5	Inflammation (Inflammations) 01/2022 - 03/2009
2	Staphylococcal Infections 10/2022 - 01/2018
2	Dysbiosis 01/2022 - 01/2019
2	Osteomyelitis 01/2020 - 01/2017
2	Infectious Arthritis (Septic Arthritis) 01/2020 - 01/2017
1	Wound Infection (Wound Infections) 10/2022
1	Bacteremia 10/2022
1	Abscess 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Dermatitis 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Allergic Rhinitis 01/2021
1	Coinfection 11/2019
1	Surgical Wound Infection 01/2019
1	Persistent Infection 01/2018
1	Hypertrophy 03/2009
1	Heart Failure 03/2009
1	Fibrosis (Cirrhosis) 03/2009
1	Hypertension (High Blood Pressure) 07/2008
1	Hypoxia (Hypoxemia) 07/2008

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2017
3	CytokinesIBA 01/2021 - 03/2009
3	Monoclonal AntibodiesIBA 01/2019 - 01/2017
2	Linezolid (Zyvox)FDA Link 10/2022 - 04/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 11/2017
2	TitaniumIBA 01/2018 - 01/2017
1	Oxazolidinones (2 Oxazolidone)IBA 10/2022
1	PlacebosIBA 10/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	DefensinsIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	butyl phosphorotrithioate (DEF)IBA 01/2022
1	tofacitinibIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	quinolineIBA 01/2021
1	quinoline-val-asp(OMe)-CH2-OPHIBA 01/2021
1	AllergensIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	KetonesIBA 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	CaspasesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	LuciferasesIBA 11/2019
1	Filaggrin ProteinsIBA 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	Interleukin-33IBA 11/2017
1	Interleukin-18 (Interleukin 18)IBA 11/2017
1	Virulence Factors (Pathogenicity Factors)IBA 11/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	factor AIBA 01/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2009
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2009
1	p38 Mitogen-Activated Protein KinasesIBA 03/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2009
1	Tumor Necrosis Factor InhibitorsIBA 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008

Therapy/Procedure

1	Immunotherapy 01/2021
1	Prostheses and Implants (Prosthesis) 01/2018